- About Us
- EFF Programs
|Letter from the President|
As 2018 begins, many of you are contemplating career choices for your life after fellowship. Opportunities in endocrinology, while much more available than in years past often are limited by fewer funded positions in academics or are geographically limited for private practice opportunities. There are two attractive career options that most fellows are not familiar with. Because of the firewalls between pharma and academic programs, exposure to career opportunities in industry are limited, and a career in pharma can offer the opportunity to pursue basic science at the highest level or advance clinical care when heading up or working with a disease state team. Career/life balance is also more available in this career path. That said, the career path in industry has two cautions. One, it is more difficult to return to or establish a clinical practice once away for a period of time. Two, your career inevitably tied to a product cycle or success and unexpected problems in drug development can lead to an abrupt unplanned job change.
The second career path which has been most common here at Northwestern and one that I’ve been able to enjoy academically and clinically for 3 decades is the Internist/Endocrinologist. While pure endocrine opportunities may not be available in your desired area, few are better suited to handle general medicine than the endocrinologist. Many if not most of your diabetic and thyroid patients are often looking to consolidate their care with a single provider and this hybrid career affords that opportunity. Ironically in an era where lab reimbursement is vanishing, compensation is often higher on the internist side than the endocrine side and practice building is significantly easier. Whatever your career path, know that you are a part of the most stimulating integrative specialty in all of medicine and your years ahead will be personally well rewarded.
Have a happy, successful New Year,